{"id":"W2745601792","doi":"10.1200/jco.2017.35.15_suppl.9011","title":"KEYNOTE-001: 3-year overall survival for patients with advanced NSCLC treated with pembrolizumab.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pembrolizumab; Discontinuation; Internal medicine; Oncology; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000864733,0.0002782466,0.0004015457,0.000222017,0.0001770104,0.0006137526,0.0003391391,0.0004506512,0.002888324],"category_scores_gemma":[0.0006841287,0.0001005635,0.0006155464,0.000247177,0.0001806903,0.0006030397,0.0003620804,0.000785405,0.0003333484],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008127542,"about_ca_system_score_gemma":0.0004092433,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005246173,"about_ca_topic_score_gemma":0.00123795,"domain_scores_codex":[0.9997879,0.00004209811,0.00001317119,0.00006632887,0.00004480829,0.00004568068],"domain_scores_gemma":[0.9996259,0.0000507396,0.0001562812,0.0000183449,0.00002075671,0.0001280618],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2230512,0.003434886,0.5176893,0.0008679304,0.002003716,0.0004691223,0.0001964633,0.00424017,0.02151171,0.0003812935,0.01994007,0.2062142],"study_design_scores_gemma":[0.01466412,0.05636283,0.9035874,0.0001235603,0.001615159,0.001418252,0.0001173735,0.00482361,0.004682713,0.0004038216,0.01215597,0.00004521063],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9900637,0.003395089,0.0002582258,0.0003795037,0.00007687214,0.0000924279,0.003175781,0.00004791508,0.002510562],"genre_scores_gemma":[0.9943006,0.0005187051,0.0001604556,0.0002552573,0.0000532594,0.00005972984,0.003789105,0.000006092867,0.0008568112],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002888324,"threshold_uncertainty_score":0.00966239,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06695172355110598,"score_gpt":0.4270492265671076,"score_spread":0.3600975030160016,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}